X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (101) 101
index medicus (101) 101
reverse transcriptase polymerase chain reaction (65) 65
cancer (57) 57
oncology (55) 55
female (53) 53
gene expression (50) 50
research (34) 34
genetic aspects (33) 33
male (33) 33
proteins (32) 32
medicine (30) 30
breast cancer (29) 29
middle aged (29) 29
prognosis (28) 28
animals (26) 26
biomarkers (26) 26
research article (26) 26
tumors (26) 26
oligonucleotide array sequence analysis (25) 25
biology (24) 24
analysis (23) 23
cell line, tumor (23) 23
chemotherapy (23) 23
health aspects (23) 23
adult (22) 22
blotting, western (22) 22
expression (22) 22
multidisciplinary sciences (22) 22
gene expression profiling (21) 21
gene expression regulation, neoplastic (21) 21
genes (21) 21
genomes (21) 21
science (21) 21
care and treatment (20) 20
aged (19) 19
rna, messenger - genetics (19) 19
signal transduction (19) 19
biomarkers, tumor - genetics (18) 18
polymerase chain reaction (18) 18
cancer therapies (17) 17
genetics (17) 17
kinases (17) 17
medical research (17) 17
mice (17) 17
proteomics (17) 17
rna (17) 17
gene-expression (16) 16
genomics (16) 16
immunohistochemistry (16) 16
medical prognosis (16) 16
metastasis (16) 16
patients (16) 16
studies (16) 16
apoptosis (15) 15
cell biology (15) 15
identification (15) 15
pathology (15) 15
survival (15) 15
therapy (15) 15
article (14) 14
biochemistry (14) 14
biochemistry & molecular biology (14) 14
breast-cancer (14) 14
dna microarrays (14) 14
mutation (14) 14
physiological aspects (14) 14
real-time polymerase chain reaction (14) 14
reverse phase protein array (14) 14
biomarkers, tumor - metabolism (13) 13
lung cancer (13) 13
cell cycle (12) 12
reproducibility of results (12) 12
reverse transcription (12) 12
ribonucleic acid--rna (12) 12
usage (12) 12
aged, 80 and over (11) 11
breast neoplasms - genetics (11) 11
breast neoplasms - metabolism (11) 11
cancers and neoplasms (11) 11
cell lines (11) 11
cluster analysis (11) 11
deoxyribonucleic acid--dna (11) 11
diagnosis (11) 11
flow cytometry (11) 11
lung neoplasms - genetics (11) 11
microrna (11) 11
personalized medicine (11) 11
resistance (11) 11
activation (10) 10
breast neoplasms - pathology (10) 10
cancer research (10) 10
cell proliferation (10) 10
cells (10) 10
mass spectrometry (10) 10
medicine, research & experimental (10) 10
microarray (10) 10
phosphorylation (10) 10
protein (10) 10
rna interference (10) 10
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
BBA - Proteins and Proteomics, ISSN 1570-9639, 06/2015, Volume 1854, Issue 6, pp. 651 - 657
Journal Article
Journal of Proteome Research, ISSN 1535-3893, 06/2014, Volume 13, Issue 6, pp. 2846 - 2855
Journal Article
Journal Article
Targeted Oncology, ISSN 1776-2596, 7/2006, Volume 1, Issue 3, pp. 151 - 167
Healthcare providers are increasingly incorporating information gleaned from genomics and proteomics in the diagnosis and treatment of cancer. These lines of... 
Medicine & Public Health | Reverse phase protein microarray | Combinatorial therapy | Targeted therapy | Signal transduction profiling | Proteomics | Oncology | Personalized molecular medicine | Biomedicine general | ONCOLOGY | Proteins | Kinases | Medical research
Journal Article
Personalized medicine, ISSN 1741-0541, 11/2007, Volume 4, Issue 4, pp. 439 - 444
Theranostics Health is a young company using mature proprietary technology to make personalized medicine possible today. The firm provides pharmaceutical... 
Reverse-phase protein microarray | Cancer diagnostics | Personalized medicine | Personalized therapy | Companion diagnostics | Proteomics | Medicine | Executives | Disease | Physicians | Hepatology | Technological change | Cancer therapies | Regulatory approval | Cancer
Journal Article
Methods in Molecular Biology, ISSN 1064-3745, 2017, Volume 1606, pp. 149 - 169
While genes and RNA encode information about cellular status, proteins are considered the engine of the cellular machine, as they are the effective elements... 
Reverse-phase protein microarray | Immunostaining | Tissue lysates | Proteomics | Cell lysates | Signal Transduction | Humans | Sensitivity and Specificity | Proteomics - methods | Protein Array Analysis - methods | Precision Medicine | Protein Interaction Maps
Journal Article
British Journal of Cancer, ISSN 0007-0920, 08/2017, Volume 117, Issue 4, pp. 494 - 502
Background: The biological mechanisms underlying early-and advanced-stage epithelial ovarian cancers (EOCs) are still poorly understood. This study explored... 
metabolism | chemo-sensitivity | ovarian cancer | reverse phase protein microarray | kinase signalling | UPFRONT CELLULAR-ENRICHMENT | SURVIVAL | METFORMIN | PROTEIN | FALLOPIAN-TUBE | LASER CAPTURE MICRODISSECTION | ORIGIN | ONCOLOGY | PATHWAY | GROWTH | NONRANDOM CHROMOSOME-ABNORMALITIES | AMP-Activated Protein Kinases - metabolism | Phosphorylation | TOR Serine-Threonine Kinases - metabolism | Humans | Middle Aged | Ovarian Neoplasms - pathology | Neoplasms, Glandular and Epithelial - metabolism | Drug Resistance, Neoplasm | Young Adult | Aged, 80 and over | Adult | Female | Ovarian Neoplasms - metabolism | Chemotherapy, Adjuvant | Paclitaxel - administration & dosage | Proto-Oncogene Proteins c-akt - metabolism | Ovarian Neoplasms - drug therapy | Forkhead Box Protein O1 - metabolism | Neoplasms, Glandular and Epithelial - pathology | Epithelium - metabolism | Signal Transduction | Carboplatin - administration & dosage | Disease Progression | Forkhead Box Protein O3 - metabolism | Neoplasms, Glandular and Epithelial - surgery | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neoplasms, Glandular and Epithelial - drug therapy | Carcinoma, Ovarian Epithelial | Protein Array Analysis | Aged | Neoplasm Staging | Ovarian Neoplasms - surgery | TOR protein | Metabolic rate | AKT protein | Activation | Metabolism | Patients | Ribosomal protein S6 kinase | Signaling | Protein arrays | FOXO1 protein | Paclitaxel | Carboplatin | Lesions | Tumors | FOXO3 protein | Translational Therapeutics
Journal Article